Negative Signaling Pathways of the Killer Cell Inhibitory Receptor and FcγRIIb1 Require Distinct Phosphatases
Neetu Gupta(National Institutes of Health), Eric O. Long(National Institutes of Health), Nicolai Wagtmann(Howard Hughes Medical Institute), Deborah N. Burshtyn(National Institutes of Health), Mario N. Lioubin(National Institutes of Health), Andrew M. Scharenberg(CTI BioPharma (Italy)), Jean-Pierre Kinet(Beth Israel Deaconess Medical Center), Larry R. Rohrschneider(Fred Hutch Cancer Center)
Cited by 92